You need to be logged in to view this video

Strategic Growth: Lessons from the Canadian Market

Released on Thursday, February 8, 2018•CANNABIS

Share
Facebook Twitter LinkedIn SMS

Greg Engel, CEO of Organigram, one of Canada's largest licensed producers, will focus on key learnings coming from the evolving Canadian cannabis market. Mr. Engel will discuss proven corporate strategies that build reputational excellence. He will also use real-life examples to illustrate how Organigram has developed its own leadership positioning becoming a strong, sustainable business that will continue to flourish as the Canadian market transitions from medical use to a legal adult recreational cannabis market.

Greg Engel

Organigram Inc, CEO

Greg Engel is CEO at Organigram Inc, a leading publicly-traded licensed producer of medicinal cannabis in Canada. A senior executive with 30 years of national and international experience in the pharmaceutical, biotechnology, cannabis, and consumer packaged goods industries, he has led the creation, development, and growth of several companies over the span of his career. An articulate and trusted voice in the burgeoning Canadian cannabis space, Mr. Engel most recently worked with a competitive licensed producer to become the first Canadian exporter of medical cannabis, as well as the establishment of several trailblazing industry standards. As leader at Organigram Inc., he is focused on reputational excellence through product quality and safety, expansion of the company's Moncton, NB facility, and production efficiencies to position the company as a leader in the medical and adult recreational cannabis industries.